Sovos Brands, Inc.
Sovos Brands, Inc. (Nasdaq: SOVO), relating to its proposed acquisition by Campbell Soup Company. Under the terms of the agreement, SOVO shareholders will receive $23.00 in cash per share they own.
Sovos Brands, Inc. (Nasdaq: SOVO), relating to its proposed acquisition by Campbell Soup Company. Under the terms of the agreement, SOVO shareholders will receive $23.00 in cash per share they own.
Veritiv Corp. (NYSE: VRTV), relating to its proposed sale to an affiliate of Clayton, Dubilier & Rice LLC. Under the terms of the agreement, VRTV shareholders will receive $170.00 in cash per share they own
Fiesta Restaurant Group, Inc. (Nasdaq: FRGI), relating to its proposed sale to Authentic Restaurant Brands. Under the terms of the agreement, FRGI shareholders will receive $8.50 in cash per share they own.
Inpixon (Nasdaq: INPX), relating to its proposed merger with XTI Aircraft Co. Under the terms of the agreement, INPX shareholders are expected to own approximately 40% of the combined company.
PacWest Bancorp (Nasdaq: PACW), relating to its proposed sale to Banc of California, Inc. Under the terms of the agreement, PACW shareholders will receive 0.6569 shares of Banc of California per share they own.
Reata Pharmaceuticals, Inc. (Nasdaq: RETA), relating to its proposed sale to Biogen, Inc. Under the terms of the agreement, RETA shareholders are expected to receive $172.50 in cash per share they own.
American National Bankshares Inc. (Nasdaq: AMNB), relating to its proposed sale to Atlantic Union Bankshares Corp. Under the terms of the agreement, AMNB shareholders will receive 1.35 shares of Atlantic per share they own.
New Relic, Inc. (NYSE: NEWR), relating to its proposed sale to Francisco Partners. Under the terms of the agreement, NEWR shareholders will receive $87.00 in cash per share they own.
Denbury, Inc. (NYSE: DEN), relating to its proposed sale to Exxon Mobil Corp. Under the terms of the agreement, DEN shareholders are expected to receive $89.45 in cash per share they own.
Frequency Therapeutics, Inc. (Nasdaq: FREQ), relating to its proposed merger with Korro Bio, Inc. Under the terms of the agreement, FREQ shareholders are expected to own approximately 8% of the combined company